Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

ClinicalTrials.gov ID: NCT00057564

Public ClinicalTrials.gov record NCT00057564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma

Study identification

NCT ID
NCT00057564
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene Corporation
Industry
Enrollment
470 participants

Conditions and interventions

Interventions

  • A (Thalidomide + Dexamethasone) Drug
  • B (Placebo + Dexamethasone) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2003
Primary completion
Mar 31, 2006
Completion
Jul 31, 2013
Last update posted
Sep 10, 2015

2003 – 2013

United States locations

U.S. sites
26
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
Clinical Research Consultants, Inc. Hoover Alabama 35216
Arizona Clinical Research Center Tucson Arizona 85712
UCLA School of Medicine Los Angeles California 90095
James Berenson West Hollywood California 90069
Mayo Clinic Jacksonville Florida 32224
Melbourne Internal Medicine Associates Oncology Melbourne Florida 32901-3182
Jackson Memorial Hospital and Clinics Miami Florida 33136
University of Miami Miller School/Jackson Memorial Hospital Miami Florida 33136
University of Miami Miami Florida 33136
Oncology Hematology Group of South Florida Miami Florida 33176
Medical College of Georgia Augusta Georgia 30912-3125
Southern Illinois Hematology /Oncology Centralia Illinois 62801
Rush Cancer Institute Section of Hematology Chicago Illinois 60612-3824
University of Iowa Hospital of Clinic Iowa City Iowa 52242
Ocshner Clinic Foundation New Orleans Louisiana 70121
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0922
Mayo Clinic Cancer Center Rochester Minnesota 55905
Hackensack University Hospital Hackensack New Jersey 07601
SUNY Upstate Medical University Syracuse New York 13210
Wake Forest University School of Medicine Winston-Salem North Carolina 27157-1023
Cleveland Clinic- Taussig Cancer Center Cleveland Ohio 44195
University of Pittsburgh Pittsburgh Pennsylvania 15213
South Carolina Oncology Group West Columbia South Carolina 29169
The Family Centre, PLLC Collierville Tennessee 38017
East Tennessee Oncology/Hematology Associates Knoxville Tennessee 37920
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00057564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2015 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00057564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →